- Home
- BEDU vs RAPT Comparison
BEDU vs RAPT Comparison
Compare BEDU & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- RAPT
- Stock Information
- Founded
- BEDU 1994
- RAPT 2015
- Country
- BEDU China
- RAPT United States
- Employees
- BEDU N/A
- RAPT N/A
- Industry
- BEDU Other Consumer Services
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- BEDU Real Estate
- RAPT Health Care
- Exchange
- BEDU Nasdaq
- RAPT Nasdaq
- Market Cap
- BEDU 58.7M
- RAPT 65.6M
- IPO Year
- BEDU 2017
- RAPT 2019
- Fundamental
- Price
- BEDU $1.93
- RAPT $1.11
- Analyst Decision
- BEDU
- RAPT Hold
- Analyst Count
- BEDU 0
- RAPT 10
- Target Price
- BEDU N/A
- RAPT $5.00
- AVG Volume (30 Days)
- BEDU 2.2K
- RAPT 995.1K
- Earning Date
- BEDU 11-29-2024
- RAPT 11-12-2024
- Dividend Yield
- BEDU N/A
- RAPT N/A
- EPS Growth
- BEDU N/A
- RAPT N/A
- EPS
- BEDU N/A
- RAPT N/A
- Revenue
- BEDU $304,874,554.00
- RAPT N/A
- Revenue This Year
- BEDU N/A
- RAPT N/A
- Revenue Next Year
- BEDU N/A
- RAPT N/A
- P/E Ratio
- BEDU N/A
- RAPT N/A
- Revenue Growth
- BEDU 12.26
- RAPT N/A
- 52 Week Low
- BEDU $1.05
- RAPT $1.03
- 52 Week High
- BEDU $3.23
- RAPT $27.35
- Technical
- Relative Strength Index (RSI)
- BEDU 49.29
- RAPT 33.55
- Support Level
- BEDU $1.79
- RAPT $1.31
- Resistance Level
- BEDU $1.95
- RAPT $1.96
- Average True Range (ATR)
- BEDU 0.10
- RAPT 0.39
- MACD
- BEDU 0.00
- RAPT -0.14
- Stochastic Oscillator
- BEDU 41.78
- RAPT 3.28
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. The company offers overseas schools, complementary education services, and domestic kindergartens and K12 operation services. The group's overseas K12 education has several K12 schools, art colleges, language training institutions, and summer schools around the world. The complimentary education services segment of the company predominantly includes camp programs, after-school programs, through a network of learning centers in China, as well as international education consulting services. Geographically, the company operates in China which is the key revenue generating market, Canada, United States, and United Kingdom.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.